Emmalene J. Bartlett

878 total citations
21 papers, 709 citations indexed

About

Emmalene J. Bartlett is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Emmalene J. Bartlett has authored 21 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 12 papers in Infectious Diseases and 8 papers in Immunology. Recurrent topics in Emmalene J. Bartlett's work include Respiratory viral infections research (11 papers), Viral Infections and Vectors (10 papers) and Virology and Viral Diseases (9 papers). Emmalene J. Bartlett is often cited by papers focused on Respiratory viral infections research (11 papers), Viral Infections and Vectors (10 papers) and Virology and Viral Diseases (9 papers). Emmalene J. Bartlett collaborates with scholars based in United States, Australia and Germany. Emmalene J. Bartlett's co-authors include Peter L. Collins, Cassandra M. James, Vanessa S. Cull, Alexander C. Schmidt, Sonja R. Surman, Jim Boonyaratanakornkit, Mario H. Skiadopoulos, Brian R. Murphy, Michael T. Marr and Dennis C. Ko and has published in prestigious journals such as Blood, Journal of Virology and Virology.

In The Last Decade

Emmalene J. Bartlett

21 papers receiving 704 citations

Peers

Countries citing papers authored by Emmalene J. Bartlett

Since Specialization

Citations

This map shows the geographic impact of Emmalene J. Bartlett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmalene J. Bartlett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmalene J. Bartlett more than expected).

Fields of papers citing papers by Emmalene J. Bartlett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmalene J. Bartlett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmalene J. Bartlett. The network helps show where Emmalene J. Bartlett may publish in the future.

Co-authorship network of co-authors of Emmalene J. Bartlett

This figure shows the co-authorship network connecting the top 25 collaborators of Emmalene J. Bartlett. A scholar is included among the top collaborators of Emmalene J. Bartlett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmalene J. Bartlett. Emmalene J. Bartlett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antigen-armed antibodies targeting B lymphoma cells effectively activate antigen-specific CD4+ T cells 2015 ·Blood ·Xiaojun Yu, (unknown), Emmalene J. Bartlett, (unknown), Rauf Bhat, Josef Mautner, Regina Feederle, Henri‐Jacques Delecluse	8
2	Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epithelium 2012 ·Virology ·Nicolaas Schaap, Rachael M. Liesman, Emmalene J. Bartlett, Margaret A. Scull, Peter L. Collins, Raymond J. Pickles, Alexander C. Schmidt	20
3	Progress in the development of human parainfluenza virus vaccines 2011 ·Expert Review of Respiratory Medicine ·Alexander C. Schmidt, Nicolaas Schaap, Emmalene J. Bartlett, (unknown), Jim Boonyaratanakornkit, Ruth A. Karron, Peter L. Collins	85
4	The C Proteins of Human Parainfluenza Virus Type 1 Limit Double-Stranded RNA Accumulation That Would Otherwise Trigger Activation of MDA5 and Protein Kinase R 2010 ·Journal of Virology ·Jim Boonyaratanakornkit, Emmalene J. Bartlett, (unknown), Sonja R. Surman, Shizuo Akira, Yong‐Soo Bae, Peter L. Collins, Brian R. Murphy, Alexander Schmidt	46
5	Epstein-Barr virus genetics: talking about the BAC generation 2010 ·PubMed ·Regina Feederle, Emmalene J. Bartlett, Henri‐Jacques Delecluse	30
6	A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidates 2009 ·Vaccine ·Emmalene J. Bartlett, (unknown), Jim Boonyaratanakornkit, (unknown), (unknown), Mario H. Skiadopoulos, Peter L. Collins, Brian R. Murphy, Alexander C. Schmidt	9
7	Role of Interferon in the Replication of Human Parainfluenza Virus Type 1 Wild Type and Mutant Viruses in Human Ciliated Airway Epithelium 2008 ·Journal of Virology ·Emmalene J. Bartlett, (unknown), Mario H. Skiadopoulos, Alexander C. Schmidt, Peter L. Collins, Brian R. Murphy, Raymond J. Pickles	27
8	Human Parainfluenza Virus Type 1 C Proteins Are Nonessential Proteins That Inhibit the Host Interferon and Apoptotic Responses and Are Required for Efficient Replication in Nonhuman Primates 2008 ·Journal of Virology ·Emmalene J. Bartlett, (unknown), (unknown), (unknown), (unknown), Sonja R. Surman, (unknown), Jim Boonyaratanakornkit, Raymond J. Pickles, Peter L. Collins, Brian R. Murphy, Alexander C. Schmidt	36
9	Attenuation and efficacy of human parainfluenza virus type 1 (HPIV1) vaccine candidates containing stabilized mutations in the P/C and L genes 2007 ·Virology Journal ·Emmalene J. Bartlett, (unknown), Sonja R. Surman, Peter L. Collins, Mario H. Skiadopoulos, Brian R. Murphy	19
10	Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein 2006 ·Vaccine ·Cassandra M. James, Mohammad Yazid Abdad, (unknown), (unknown), (unknown), Philip A. Stumbles, Emmalene J. Bartlett	39
11	Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1 2006 ·Virology ·Wil Van Cleve, Emérito Amaro-Carambot, Sonja R. Surman, Joseph Bekisz, Peter L. Collins, Kathryn C. Zoon, Brian R. Murphy, Mario H. Skiadopoulos, Emmalene J. Bartlett	34
12	Introducing point and deletion mutations into the P/C gene of human parainfluenza virus type 1 (HPIV1) by reverse genetics generates attenuated and efficacious vaccine candidates 2005 ·Vaccine ·Emmalene J. Bartlett, Emérito Amaro-Carambot, Sonja R. Surman, Peter L. Collins, Brian R. Murphy, Mario H. Skiadopoulos	23
13	Human parainfluenza virus type I (HPIV1) vaccine candidates designed by reverse genetics are attenuated and efficacious in African green monkeys 2005 ·Vaccine ·Emmalene J. Bartlett, Emérito Amaro-Carambot, Sonja R. Surman, Jason T. Newman, Peter L. Collins, Brian R. Murphy, Mario H. Skiadopoulos	34
14	Type I IFN‐β gene therapy suppresses cardiac CD8⁺ T‐cell infiltration during autoimmune myocarditis 2004 ·Immunology and Cell Biology ·Emmalene J. Bartlett, Jason C. Lenzo, (unknown), (unknown), Vanessa S. Cull, Cassandra M. James	19
15	Optimization of naked DNA delivery for interferon subtype immunotherapy in cytomegalovirus infection 2003 ·Biological Procedures Online ·Emmalene J. Bartlett, Vanessa S. Cull, Eva N. Mowe, (unknown), Cassandra M. James	4
16	Type I interferon differential therapy for erythroleukemia: specificity of STAT activation 2003 ·Blood ·Vanessa S. Cull, Peta A. Tilbrook, Emmalene J. Bartlett, (unknown), Cassandra M. James	58
17	Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice 2002 ·Gene Therapy ·Vanessa S. Cull, (unknown), Emmalene J. Bartlett, (unknown), Cassandra M. James	35
18	Synergy of type I interferon‐A6 and interferon‐B naked DNA immunotherapy for cytomegalovirus infection 2002 ·Immunology and Cell Biology ·Emmalene J. Bartlett, Vanessa S. Cull, (unknown), Jason C. Lenzo, Cassandra M. James	8
19	Type I interferon gene therapy protects against cytomegalovirus‐induced myocarditis 2002 ·Immunology ·Vanessa S. Cull, Emmalene J. Bartlett, Cassandra M. James	37
20	Antitermination by Bacteriophage Q Protein 1998 ·Cold Spring Harbor Symposia on Quantitative Biology ·Jeffrey W. Roberts, (unknown), Emmalene J. Bartlett, (unknown), Michael T. Marr, Dennis C. Ko, (unknown), Charles W.M. Roberts	124

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact